Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Publishing of Annual individual audited financial statement for 2025
Regulatory Filings
2026-03-30 Polish
Notification for sale of treasury shares
Transaction in Own Shares Classification · 90% confidence The document is a current report under EU Market Abuse Regulation (EU) No 596/2014, detailing the sale of treasury shares (250,000 shares) by the company. This constitutes a transaction in the company’s own shares (selling treasury stock). It does not announce dividends, management changes, or financial results, but specifically reports a share repurchase/sale event. Therefore, it matches the “Transaction in Own Shares” category.
2026-03-30 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 99% confidence The text is a regulatory ‘Current report’ notifying of the sale of treasury shares (company’s own shares) under EU Market Abuse Regulation. This is a transaction in own shares announcement, matching Code POS.
2026-03-27 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 99% confidence The document is a regulatory announcement under EU MAR article 17, detailing the disposal of treasury shares by the company (sold 40,911 shares). This clearly falls under the category of a share buyback/disposal, which corresponds to Transaction in Own Shares (Code: POS).
2026-03-26 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 95% confidence The document is a current report notifying the sale of the company’s treasury shares on the stock exchange under EU Regulation 596/2014. This clearly falls under 'Transaction in Own Shares' (Code POS).
2026-03-25 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 95% confidence The document is a current report under EU Market Abuse Regulation art.17 notifying the sale of treasury shares. It details the number of shares sold, percentage of share capital, and total value—an insider transaction in the company’s own shares (treasury stock) rather than an earnings report or general announcement. This aligns precisely with the “Transaction in Own Shares” category (POS).
2026-03-24 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.